- Home
- NCRA vs RDHL Comparison
NCRA vs RDHL Comparison
Compare NCRA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- RDHL
- Stock Information
- Founded
- NCRA 2002
- RDHL 2009
- Country
- NCRA Taiwan
- RDHL Israel
- Employees
- NCRA N/A
- RDHL N/A
- Industry
- NCRA Farming/Seeds/Milling
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- RDHL Health Care
- Exchange
- NCRA Nasdaq
- RDHL Nasdaq
- Market Cap
- NCRA 15.4M
- RDHL 13.1M
- IPO Year
- NCRA N/A
- RDHL N/A
- Fundamental
- Price
- NCRA $1.17
- RDHL $8.16
- Analyst Decision
- NCRA
- RDHL
- Analyst Count
- NCRA 0
- RDHL 0
- Target Price
- NCRA N/A
- RDHL N/A
- AVG Volume (30 Days)
- NCRA 5.8K
- RDHL 37.3K
- Earning Date
- NCRA 08-14-2024
- RDHL 10-15-2024
- Dividend Yield
- NCRA N/A
- RDHL N/A
- EPS Growth
- NCRA N/A
- RDHL N/A
- EPS
- NCRA N/A
- RDHL N/A
- Revenue
- NCRA $26,403,874.00
- RDHL $3,707,000.00
- Revenue This Year
- NCRA N/A
- RDHL $224.90
- Revenue Next Year
- NCRA N/A
- RDHL $82.69
- P/E Ratio
- NCRA N/A
- RDHL N/A
- Revenue Growth
- NCRA 33.73
- RDHL N/A
- 52 Week Low
- NCRA $0.73
- RDHL $6.43
- 52 Week High
- NCRA $1.60
- RDHL $82.00
- Technical
- Relative Strength Index (RSI)
- NCRA 63.58
- RDHL 40.13
- Support Level
- NCRA $1.16
- RDHL $7.95
- Resistance Level
- NCRA $1.10
- RDHL $9.05
- Average True Range (ATR)
- NCRA 0.10
- RDHL 0.61
- MACD
- NCRA 0.02
- RDHL -0.20
- Stochastic Oscillator
- NCRA 84.21
- RDHL 6.73
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.